1887

Journal of General Virology header logo

Volume 95, Issue 1

Evidence of subclinical prion disease in aged mice following exposure to bovine spongiform encephalopathy Free

Abstract

The occurrence of variant Creutzfeldt–Jakob (vCJD) disease in humans was almost certainly the result of consumption of food contaminated with bovine spongiform encephalopathy (BSE) prions. Despite probable widespread exposure of the UK population to BSE-contaminated food in the 1980s, vCJD has been identified predominantly in young individuals, and there have been fewer cases of clinical disease than anticipated. The reasons for this are uncertain. Following peripheral exposure, many prions replicate within the lymphoid tissues before infecting the central nervous system. We have shown that the effects of host age on the microarchitecture of the spleen significantly impair susceptibility to mouse-adapted prions after peripheral exposure. The transmission of prions between different mammalian species is considered to be limited by the ‘species barrier’, which is dependent on several factors, including an intact immune system. Thus, cross-species prion transmission may be much less efficient in aged individuals. To test this hypothesis, we compared prion pathogenesis in groups of young (6–8 weeks old) and aged (600 days old) mice injected with primary BSE brain homogenate. We showed that prion pathogenesis was impaired dramatically in aged mice when compared with young animals. Whereas most young mice succumbed to clinical prion disease, all aged mice failed to develop clinical disease during their lifespans. However, the demonstration that prion accumulation was detected in the lymphoid tissues of some aged mice after injection with primary BSE brain homogenate, in the absence of clinical signs of prion disease, has important implications for human health.

  • Received:
  • Accepted:
  • Published Online:
© 2014 SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.058958-0
2014-01-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/1/231.html?itemId=/content/journal/jgv/10.1099/vir.0.058958-0&mimeType=html&fmt=ahah

References

  1. Andréoletti O., Berthon P., Marc D., Sarradin P., Grosclaude J., van Keulen L., Schelcher F., Elsen J.-M., Lantier F. 2000; Early accumulation of PrPSc in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J Gen Virol 81:3115–3126[PubMed]
     [Google Scholar]
  2. Aydar Y., Balogh P., Tew J. G., Szakal A. K. 2002; Age-related depression of FDC accessory functions and CD21 ligand-mediated repair of co-stimulation. Eur J Immunol 32:2817–2826 [View Article][PubMed]
     [Google Scholar]
  3. Aydar Y., Balogh P., Tew J. G., Szakal A. K. 2003; Altered regulation of Fc gamma RII on aged follicular dendritic cells correlates with immunoreceptor tyrosine-based inhibition motif signaling in B cells and reduced germinal center formation. J Immunol 171:5975–5987[PubMed] [CrossRef]
     [Google Scholar]
  4. Barron R. M., Thomson V., Jamieson E., Melton D. W., Ironside J., Will R., Manson J. C. 2001; Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J 20:5070–5078 [View Article][PubMed]
     [Google Scholar]
  5. Birjandi S. Z., Ippolito J. A., Ramadorai A. K., Witte P. L. 2011; Alterations in marginal zone macrophages and marginal zone B cells in old mice. J Immunol 186:3441–3451 [View Article][PubMed]
     [Google Scholar]
  6. Bishop M. T., Hart P., Aitchison L., Baybutt H. N., Plinston C., Thomson V., Tuzi N. L., Head M. W., Ironside J. W., Will R. G. 2006; Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5:393–398 [View Article][PubMed]
     [Google Scholar]
  7. Bishop M. T., Diack A. B., Ritchie D. L., Ironside J. W., Will R. G., Manson J. C. 2013; Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt–Jakob disease. Brain 136:1139–1145 [View Article][PubMed]
     [Google Scholar]
  8. Boëlle P.-Y., Cesbron J.-Y., Valleron A.-J. 2004; Epidemiological evidence of higher susceptibility to vCJD in the young. BMC Infect Dis 4:26 [View Article][PubMed]
     [Google Scholar]
  9. Bolton D. C., McKinley M. P., Prusiner S. B. 1982; Identification of a protein that purifies with the scrapie prion. Science 218:1309–1311 [View Article][PubMed]
     [Google Scholar]
  10. Brown K. L., Stewart K., Bruce M. E., Fraser H. 1997; Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy. J Gen Virol 78:2707–2710[PubMed]
     [Google Scholar]
  11. Brown K. L., Stewart K., Ritchie D. L., Mabbott N. A., Williams A., Fraser H., Morrison W. I., Bruce M. E. 1999; Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat Med 5:1308–1312 [View Article][PubMed]
     [Google Scholar]
  12. Brown K. L., Wathne G. J., Sales J., Bruce M. E., Mabbott N. A. 2009; The effects of host age on follicular dendritic cell status dramatically impair scrapie agent neuroinvasion in aged mice. J Immunol 183:5199–5207 [View Article][PubMed]
     [Google Scholar]
  13. Brown K. L., Gossner A., Mok S., Mabbott N. A. 2012; The effects of host age on the transport of complement-bound complexes to the spleen and the pathogenesis of intravenous scrapie infection. J Virol 86:25–35 [View Article][PubMed]
     [Google Scholar]
  14. Bruce M. E., Will R. G., Ironside J. W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J. other authors 1997; Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498–501 [View Article][PubMed]
     [Google Scholar]
  15. Cancellotti E., Mahal S. P., Somerville R., Diack A., Brown D., Piccardo P., Weissmann C., Manson J. C. 2013; Post-translational changes to PrP alter transmissible spongiform encephalopathy strain properties. EMBO J 32:756–769 [View Article][PubMed]
     [Google Scholar]
  16. Cinamon G., Zachariah M. A., Lam O. M., Foss F. W. Jr, Cyster J. G. 2008; Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 9:54–62 [View Article][PubMed]
     [Google Scholar]
  17. Clewley J. P., Kelly C. M., Andrews N., Vogliqi K., Mallinson G., Kaisar M., Hilton D. A., Ironside J. W., Edwards P. other authors 2009; Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 338:b1442 [View Article][PubMed]
     [Google Scholar]
  18. Farquhar C. F., Somerville R. A., Ritchie L. A. 1989; Post-mortem immunodiagnosis of scrapie and bovine spongiform encephalopathy. J Virol Methods 24:215–221 [View Article][PubMed]
     [Google Scholar]
  19. Fraser H., Bruce M. E., Chree A., McConnell I., Wells G. A. H. 1992; Transmission of bovine spongiform encephalopathy and scrapie to mice. J Gen Virol 73:1891–1897 [View Article][PubMed]
     [Google Scholar]
  20. Frigg R., Klein M. A., Hegyi I., Zinkernagel R. M., Aguzzi A. 1999; Scrapie pathogenesis in subclinically infected B-cell-deficient mice. J Virol 73:9584–9588[PubMed]
     [Google Scholar]
  21. Garske T., Ghani A. C. 2010; Uncertainty in the tail of the variant Creutzfeldt–Jakob disease epidemic in the UK. PLoS ONE 5:e15626 [View Article][PubMed]
     [Google Scholar]
  22. Ghani A. C., Ferguson N. M., Donnelly C. A., Anderson R. M. 2000; Predicted vCJD mortality in Great Britain. Nature 406:583–584 [View Article][PubMed]
     [Google Scholar]
  23. Hill A. F., Joiner S., Linehan J., Desbruslais M., Lantos P. L., Collinge J. 2000; Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A 97:10248–10253 [View Article][PubMed]
     [Google Scholar]
  24. Hilton D. A., Fathers E., Edwards P., Ironside J. W., Zajicek J. 1998; Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt–Jakob disease. Lancet 352:703–704 [View Article][PubMed]
     [Google Scholar]
  25. Hilton D. A., Ghani A. C., Conyers L., Edwards P., McCardle L., Penney M., Ritchie D., Ironside J. W. 2002; Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 325:633–634 [View Article][PubMed]
     [Google Scholar]
  26. Hilton D. A., Ghani A. C., Conyers L., Edwards P., McCardle L., Ritchie D., Penney M., Hegazy D., Ironside J. W. 2004; Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203:733–739 [View Article][PubMed]
     [Google Scholar]
  27. Houston F., Goldmann W., Chong A., Jeffrey M., González L., Foster J., Parnham D., Hunter N. 2003; Prion diseases: BSE in sheep bred for resistance to infection. Nature 423:498 [View Article][PubMed]
     [Google Scholar]
  28. Klein M. A., Kaeser P. S., Schwarz P., Weyd H., Xenarios I., Zinkernagel R. M., Carroll M. C., Verbeek J. S., Botto M. other authors 2001; Complement facilitates early prion pathogenesis. Nat Med 7:488–492 [View Article][PubMed]
     [Google Scholar]
  29. Lanoue A., Clatworthy M. R., Smith P., Green S., Townsend M. J., Jolin H. E., Smith K. G., Fallon P. G., McKenzie A. N. 2004; SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J Exp Med 200:1383–1393 [View Article][PubMed]
     [Google Scholar]
  30. Legname G., Baskakov I. V., Nguyen H.-O. B., Riesner D., Cohen F. E., DeArmond S. J., Prusiner S. B. 2004; Synthetic mammalian prions. Science 305:673–676 [View Article][PubMed]
     [Google Scholar]
  31. Lloyd S. E., Thompson S. R., Beck J. A., Linehan J. M., Wadsworth J. D. F., Brandner S., Collinge J., Fisher E. M. 2004; Identification and characterization of a novel mouse prion gene allele. Mamm Genome 15:383–389 [View Article][PubMed]
     [Google Scholar]
  32. Mabbott N. A. 2012; Prion pathogenesis and secondary lymphoid organs (SLO): tracking the SLO spread of prions to the brain. Prion 6:322–333 [View Article][PubMed]
     [Google Scholar]
  33. Mabbott N. A., Mackay F., Minns F., Bruce M. E. 2000; Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med 6:719–720 [View Article][PubMed]
     [Google Scholar]
  34. Mabbott N. A., Bruce M. E., Botto M., Walport M. J., Pepys M. B. 2001; Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med 7:485–487 [View Article][PubMed]
     [Google Scholar]
  35. Mabbott N. A., Young J., McConnell I., Bruce M. E. 2003; Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J Virol 77:6845–6854 [View Article][PubMed]
     [Google Scholar]
  36. McBride P. A., Eikelenboom P., Kraal G., Fraser H., Bruce M. E. 1992; PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J Pathol 168:413–418 [View Article][PubMed]
     [Google Scholar]
  37. McCulloch L., Brown K. L., Bradford B. M., Hopkins J., Bailey M., Rajewsky K., Manson J. C., Mabbott N. A. 2011; Follicular dendritic cell-specific prion protein (PrPC) expression alone is sufficient to sustain prion infection in the spleen. PLoS Pathog 7:e1002402 [View Article][PubMed]
     [Google Scholar]
  38. McCulloch L., Brown K. L., Mabbott N. A. 2013; Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function. Immunology 138:246–257 [View Article][PubMed]
     [Google Scholar]
  39. Mebius R. E., Kraal G. 2005; Structure and function of the spleen. Nat Rev Immunol 5:606–616 [View Article][PubMed]
     [Google Scholar]
  40. Michel B., Ferguson A., Johnson T., Bender H., Meyerett-Reid C., Pulford B., von Teichman A., Seelig D., Weis J. H. other authors 2012; Genetic depletion of complement receptors CD21/35 prevents terminal prion disease in a mouse model of chronic wasting disease. J Immunol 189:4520–4527 [View Article][PubMed]
     [Google Scholar]
  41. Montrasio F., Frigg R., Glatzel M., Klein M. A., Mackay F., Aguzzi A., Weissmann C. 2000; Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288:1257–1259 [View Article][PubMed]
     [Google Scholar]
  42. O’Connor T., Frei N., Sponarova J., Schwarz P., Heikenwalder M., Aguzzi A. 2012; Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes. PLoS Pathog 8:e1002867 [View Article][PubMed]
     [Google Scholar]
  43. Peden A. H., Head M. W., Diane L. R., Bell J. E., Ironside J. W. 2004; Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527–529 [View Article][PubMed]
     [Google Scholar]
  44. Prusiner S. B., Scott M., Foster D., Pan K. M., Groth D., Mirenda C., Torchia M., Yang S. L., Serban D. other authors 1990; Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63:673–686 [View Article][PubMed]
     [Google Scholar]
  45. Schulz-Schaeffer W. J., Tschöke S., Kranefuss N., Dröse W., Hause-Reitner D., Giese A., Groschup M. H., Kretzschmar H. A. 2000; The paraffin-embedded tissue blot detects PrPSc early in the incubation time in prion diseases. Am J Pathol 156:51–56 [View Article][PubMed]
     [Google Scholar]
  46. Sigurdson C. J., Williams E. S., Miller M. W., Spraker T. R., O’Rourke K. I., Hoover E. A. 1999; Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Virol 80:2757–2764[PubMed]
     [Google Scholar]
  47. Somerville R. A., Hamilton S., Fernie K. 2005; Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc. . J Gen Virol 86:241–246 [View Article][PubMed]
     [Google Scholar]
  48. Taylor P. R., Pickering M. C., Kosco-Vilbois M. H., Walport M. J., Botto M., Gordon S., Martinez-Pomares L. 2002; The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues. Eur J Immunol 32:1883–1896 [View Article][PubMed]
     [Google Scholar]
  49. Thackray A. M., Klein M. A., Bujdoso R. 2003; Subclinical prion disease induced by oral inoculation. J Virol 77:7991–7998 [View Article][PubMed]
     [Google Scholar]
  50. Valleron A.-J., Boelle P.-Y., Will R., Cesbron J.-Y. 2001; Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 294:1726–1728 [View Article][PubMed]
     [Google Scholar]
  51. Wilesmith J. W. 1993; BSE: Epidemiological approaches, trials and tribulations. Prev Vet Med 18:33–42 [View Article]
     [Google Scholar]
  52. Will R. G., Ironside J. W., Zeidler M., Estibeiro K., Cousens S. N., Smith P. G., Alperovitch A., Poser S., Pocchiari M., Hofman A. 1996; A new variant of Creutzfeldt–Jakob disease in the UK. Lancet 347:921–925 [View Article][PubMed]
     [Google Scholar]
  53. Zabel M. D., Heikenwalder M., Prinz M., Arrighi I., Schwarz P., Kranich J., von Teichman A., Haas K. M., Zeller N. other authors 2007; Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. J Immunol 179:6144–6152[PubMed] [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.058958-0
Loading
Evidence of subclinical prion disease in aged mice following exposure to bovine spongiform encephalopathy
J. Gen. Virol. 95, 231 (2014); https://doi.org/10.1099/vir.0.058958-0
/content/journal/jgv/10.1099/vir.0.058958-0
/content/journal/jgv/10.1099/vir.0.058958-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error